17 results
424B3
CHRO
Chromocell Therapeutics Corp
16 Apr 24
Prospectus supplement
5:49pm
be updated annually and amended when certain changes are made;
approval by an institutional review board (“IRB”) or independent ethics committee … a clinical trial at a specific study site after the competent ethics committee (the “EC”), has issued a favorable opinion. The clinical trial
424B3
CHRO
Chromocell Therapeutics Corp
16 Apr 24
Prospectus supplement
5:45pm
be updated annually and amended when certain changes are made;
approval by an institutional review board (“IRB”) or independent ethics committee … a clinical trial at a specific study site after the competent ethics committee (the “EC”), has issued a favorable opinion. The clinical trial
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp
16 Apr 24
Annual report
4:48pm
be updated annually and amended when certain changes are made;
approval by an institutional review board (“IRB”) or independent ethics committee (“IEC … a clinical trial at a specific study site after the competent ethics committee (the “EC”), has issued a favorable opinion. The clinical trial application
424B4
CHRO
Chromocell Therapeutics Corp
20 Feb 24
Prospectus supplement with pricing info
5:30pm
by an institutional review board (“IRB”) or independent ethics committee (“IEC”) at each clinical trial site before each trial may be initiated … may only start a clinical trial at a specific study site after the competent ethics committee (the “EC”), has issued a favorable opinion. The clinical
424B4
CHRO
Chromocell Therapeutics Corp
20 Feb 24
Prospectus supplement with pricing info
5:28pm
review board (“IRB”) or independent ethics committee (“IEC”) at each clinical trial site before each trial may be initiated;
performance of adequate … a clinical trial at a specific study site after the competent ethics committee (the “EC”), has issued a favorable opinion. The clinical trial application
DRS/A
0yzpemmx 6jwh7qah
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next